玲珮玎珰

在FDA网站和wiki上验证了你说的信息，见下。

Table 1 Past Approvals for Non-Hodgkin’s Lymphoma (Reviewer Table)
Drug Approval Date Indication

Vincristine July 10, 1963 In combination with other chemotherapeutic agents in the treatment of Non-Hodgkin’s lymphomas
Vinblastine November 25, 1965 For the treatment of Non-Hodgkin’s
lymphomas

http://en.wikipedia.org/wiki/Vincristine

Vincristine (brand name, Oncovin), also known as leurocristine, is a vinca alkaloid from the Catharanthus roseus (Madagascar periwinkle), formerly Vinca rosea and hence its name. It is a mitotic inhibitor, and is used in cancer chemotherapy.

它们通过抑制有丝分裂过程中的微管聚合起到抗癌作用。

Vincristine was approved by the United States Food and Drug Administration (FDA) in July 1963 as Oncovin. The drug was initially discovered by a team lead by Dr. J.G. Armstrong; it was then marketed by Eli Lilly and Company。

此文于2010年4月14日星期三12:24 pm发表于“科普”分类下。您可以通过RSS 2.0 feed来跟踪此文的所有评论。您可以留言，或者从您自己的网站trackback。